A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

NCT07543731 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

5995

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases
Atherosclerotic Cardiovascular Disease
Hypercholesterolemia, Familial

Sponsor

Novartis Pharmaceuticals